PCSK9 and atherosclerosis: These findings suggest that fc-PCSK9 may also be important in the progression of atherosclerosis and the development of CVD, and therefore any targeted inhibition of furin could potentially help prevent CVD by additionally reducing levels of fc-PCSK9.